Drugs will cure cancer: Dosterlimeb will cure cancer forever, 100% efficacy in trials, even before chemotherapy and radiation are not required

For the first time in history, a drug 100% effective The great success of the medical world has shocked the whole world.In a recent clinical trial of some patients with rectal cancer, a drug called dosterlimeb has been reported.With the help of it, patients have been completely cured of cancer in just 6 months.  The research cogni 5 in the New England Journal of Medicine:

   For the first time in history the author of a drug 100% effective study Dr.Lewis A.Diaz says that for the first time in the history of cancer, all patients were cured by a single drug.So far there is no drug or treatment that can cure cancer forever. 

     Although this study is small, it is a great success for us against malignant cancer. As well as Dr.of the University of California.  According to Alan P. Winuk, every patient's recovery from cancer research is a great achievement in itself. 18 patients were included in the share trial. After 12 months, the results showed that the tumor in the patient's body had completely disappeared. 

       Tumors disappeared from all patients' bodies The trial involved 18 patients with rectal cancer living in the United States.They were all in the same stage of cancer.That means the cancer was in their rectum and did not spread to other organs.Scientists gave him a dose of Dosterlimeb continuously for 6 months.After 12 months, the results showed that the tumor in the patient's body had completely disappeared.

          These patients were then subjected to a physical examination, endoscopy, PET scan or MRI scan, but no examination revealed a tumor.According to the New York Times, all patients had undergone treatment such as chemotherapy, radiation and invasive surgery before the clinical trial.As a side effect he had problems with urine, bowel, and sex.However, no side effects of Dosterlimeb drug were found in any of the patients.| UTTOK: HEMOTA ad THERAPY 5S?

            All patients had undergone treatment like chemotherapy, radiation and invasive surgery before the clinical trial.What is Dosterlimeb Drug? Dosterlimeb is a drug made in the lab, which acts as a substitute for antibodies in the human body.  

         અહીંથી માહિતી વાંચો

             People with cancer have a weakened immune system, which can lead to low levels of antibodies.  In such cases, external medicine is needed to fight the disease.Dosterlimeb is also used to treat endometrial cancer. It was approved in 2021 in the US and Europe. Tesaro, the company that manufactures it, started making it in the year 2020.